Amylyx was started in 2013 by two Brown University undergraduates who proposed a proprietary combination of two known drugs to treat ALS. In the Fall of 2020, the successful results of their clinical trial were published in the New England Journal of Medicine. It showed that patients lived longer an ...
Reference no: 1117183
Posted on: 09/30/2021